Vials with the Pfizer BioNTech vaccine.
The pharmaceutical companies BioNTech and Pfizer have asked the European Medicines Agency (EMA) to extend the authorization of their coronavirus vaccine to adolescents between 12 and 15 years old , both companies reported today.
In a joint statement, they explain that they tested their formula against the coronavirus in 2,260 adolescents in phase three and that, as they announced at the end of March, the effectiveness of the vaccine was 100% and with a “solid” immune response.
The German BioNTech and the American Pfizer also indicate that they have already taken a similar step in the United States , where they have requested that their current emergency permit be adapted, and that they plan to request the same in other districts.
Creating a completely different series based on a universe that knows half the world can't… Read More
The strikes of scriptwriters and actors have put in check the constant flow of content to… Read More
Money Heist has returned to Netflix. This time as a prequel to the original series… Read More
One of the 50 best war films in cinema history turns 25 years old. And it is not… Read More
What is the singapore kiss In short, it is about emulating during intercourse, through the… Read More
Regarding patents, Sony is one of the technology companies that has carried out the most registrations in… Read More
